UK NHS plans to genetically test every newborn baby to identify disease

By Matthew Griffin Enhanced Humans and Biotech 24th September 2025

WHY THIS MATTERS IN BRIEF

Many diseases are the result of genetic variations so identifying those early could help the NHS prevent and cure diseases before they affect peoples lives.

Love the Exponential Future? Join our XPotential Community, future proof yourself with courses from XPotential University, read about exponential tech and trends, connect, watch a keynote, or browse my blog.

Every baby in England is to have a DNA screening to avoid fatal diseases and receive personalised healthcare as part of the government’s £650m investment in DNA technology, it has been reported.

New Anti-CRISPRs have been found in bacteria for the first time

Within a decade, every newborn will undergo whole genome sequencing, which assesses the risk of hundreds of diseases and is expected to form part of the government’s 10-year plan for the health service.

Wes Streeting, the health secretary, told the Telegraph the advances in genomics would allow people to “leapfrog” killer illnesses and receive “personalised” health care.

The Future of Healthcare, by Keynote Matthew Griffin

He said: “The revolution in medical science means that we can transform the NHS over the coming decade, from a service which diagnoses and treats ill health to one that predicts and prevents it.

“Genomics presents us with the opportunity to leapfrog disease, so we’re in front of it rather than reacting to it.”

This AI reads your mind to recreate the faces you're thinking of

Streeting added: “With the power of this new technology, patients will be able to receive personalised healthcare to prevent ill health before symptoms begin, reducing the pressure on NHS services and helping people live longer, healthier lives.”

All new parents are now offered a blood spot test for their babies, normally when the child is five days old, to check whether they have any of nine rare but serious conditions. The newborn’s heel is pricked to collect a few drops of blood on a card that is sent away to be tested.

Along with a greater focus on prevention, the 10-year plan is expected to include Streeting’s other “shifts” in the NHS, from hospitals towards more community-focused care and from analogue to digital services.

World first as Chinese scientists clone two monkeys, raising fears humans could be next

Last week the chancellor, Rachel Reeves, announced that the government would increase NHS funding by £29bn a year in real terms over the next three years.

A Department of Health and Social Care spokesperson said: “Our 10-year health plan will be published soon and will set out details for a range of initiatives to advance the NHS and make it fit for the future.”

In October, the NHS in England announced it was to screen 100,000 newborn babies for more than 200 genetic conditions in a world-first scheme aimed at bolstering early diagnosis and treatment.

Matthew Griffin / About Author

Described by NASA as a "Walking Encyclopaedia of the Future" and one of the world’s most in demand keynote speakers Matthew Griffin, Founder and Futurist in Chief of the 311 Institute, a global Futures and Deep Futures advisory firm, is a multi-award winning Futurist and strategic foresight expert, author, lecturer, mentor, podcast and YouTube host.

With a distinguished career running global business units at Atos, EMC, and IBM today Matthew helps leaders and titans of industry from all over the world explore the impact of the inter sections of technology, culture, and leadership, then helps them create high performance organisations that can continuously disrupt, outpace, and outthink their competition.

15 times author of the hit series the Codex of the Future series Matthew's ability to identify, track, and explain the impacts of hundreds of emerging technologies and trends on global business, culture, and society has earned him a powerful reputation and a roster of clients that include royal households, world leaders across the G7, G20, and G77, and many of the world's most recognised and exceptional organisations including ABB, Accenture, ABN Amro, Adidas, AON, ARM, BCG, Centrica, Citi Group, Coca Cola, Deloitte, Dentons, Disney, Dow, EY, Google, KPMG, Lego, Microsoft, Legal & General, LinkedIn, Nokia, Paramount, PepsiCo, PWC, Qualcomm, RWE, Samsung, T-Mobile, UBS, Visa, WIRED, WPP and hundreds of others.

Matthew is regularly featured in the global media including the AP, BBC, Bloomberg, CNBC, Discovery, Forbes, Khaleej Times, Telegraph, TIME, ViacomCBS, WIRED, and the WSJ, and his mission is to help organisations create a fair and sustainable future whose benefits are shared by everyone irrespective of their ability, background, or circumstances.